Geller Advisors’s Genmab GMAB Stock Holding History

Geller Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$358K	Hold	17,140	–	–	0.02%	179
2024 Q3	$418K	Hold	17,140	–	–	0.03%	160
2024 Q2	$431K	Hold	17,140	–	–	0.03%	160
2024 Q1	$513K	Sell	17,140 -10,160	-37%	-$298K	0.04%	136
2023 Q4	$869K	Hold	27,300	–	–	0.08%	76
2023 Q3	$963K	Sell	27,300 -50	-0.2%	-$1.91K	0.11%	60
2023 Q2	$1.04M	Buy	27,350 +12,770	+88%	+$509K	0.13%	52
2023 Q1	$551K	Buy	14,580 +7,240	+99%	+$278K	0.08%	60
2022 Q4	$311K	Sell	7,340 -1,170	-14%	-$48.2K	0.05%	91
2022 Q3	$273K	Sell	8,510 -610	-7%	-$21.4K	0.06%	87
2022 Q2	$296K	Hold	9,120	–	–	0.06%	86
2022 Q1	$330K	Hold	9,120	–	–	0.06%	94
2021 Q4	$361K	Hold	9,120	–	–	0.07%	97
2021 Q3	$399K	Hold	9,120	–	–	0.09%	71
2021 Q2	$372K	Buy	+9,120	New	+$352K	0.08%	71
2021 Q1	–	Sell	-8,690	Closed	-$353K	–	128
2020 Q4	$353K	Hold	8,690	–	–	0.09%	62
2020 Q3	$318K	Buy	8,690 +2,670	+44%	+$96.5K	0.09%	54
2020 Q2	$204K	Buy	+6,020	New	+$164K	0.06%	79

Other funds holding GMAB

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geller Advisors's GMAB Position: Q4 2024 in Review

Geller Advisors held its Genmab (GMAB) position steady in Q4 2024 at 17,140 shares worth $358K. The position accounts for 0.02% of the portfolio, ranked #179.

Geller Advisors first reported a position in GMAB in Q2 2020 and has held it in 18 quarters since. The position peaked at $1.04M in Q2 2023. 228 funds tracked by Wall St. Rank hold GMAB as of Q4 2024.

Geller Advisors held 17,140 shares of Genmab worth $358K as of Q4 2024.
Geller Advisors left its Genmab share count unchanged in Q4 2024.
Genmab made up 0.02% of Geller Advisors's portfolio in Q4 2024, its #179 holding.
Geller Advisors first reported a position in Genmab in Q2 2020 and has held it in 18 quarters since.
Geller Advisors's Genmab position peaked at $1.04M in Q2 2023.
228 funds tracked by Wall St. Rank held Genmab as of Q4 2024.

Based on Geller Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.